Tools for the Integrated Management of Childhood Illness: Cross-country Quasi-experimental Pre-post Study in Kenya and Senegal

NCT05065320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51590

Last updated 2023-10-31

No results posted yet for this study

Summary

By introducing pulse oximetry, with or without clinical decision support algorithms, to primary care facilities in India, Kenya, Senegal and Tanzania, the Tools for Integrated Management of Childhood Illness (TIMCI) project aims to contribute to reducing morbidity and mortality for sick children under-five while supporting the rational and efficient use of diagnostics and medicines by healthcare providers.

The multi-country, multi-method evaluation aims to generate evidence on the health and quality of care impact, operational priorities, cost and cost-effectiveness of introducing these tools to facilitate national and international decision-making on scale-up.

Conditions

  • Childhood Severe Illness
  • Pneumonia
  • Primary Health Care
  • Hypoxia
  • Referreal and Consultation
  • Decision Support Systems, Clinical
  • Oxymetry

Sponsors & Collaborators

  • PATH

    collaborator OTHER
  • University of Nairobi

    collaborator OTHER
  • Cheikh Anta Diop University, Senegal

    collaborator OTHER
  • Burnet Institute

    collaborator OTHER
  • Swiss Tropical & Public Health Institute

    lead OTHER

Principal Investigators

  • Kaspar Wyss, Prof, PhD · Swiss Tropical & Public Health Institute

  • Valérie D'Acremont, MD, PhD · Swiss Tropical & Public Health Institute

Eligibility

Min Age
1 Day
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Kenya
  • Senegal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05065320 on ClinicalTrials.gov